The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of molecular profile on switch maintenance to paclitaxel plus ramucirumab (PTX-RAM) versus continuation of first-line fluoropyrimidine and oxaliplatin (FOX) chemotherapy (ChT) in patients (pts) with advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) cancer: An exploratory endpoint of the ARMANI phase 3 randomized trial.
 
Paolo Manca
No Relationships to Disclose
 
Margherita Ambrosini
No Relationships to Disclose
 
Alessandra Raimondi
Consulting or Advisory Role - MSD; Nordic Bioscience
Travel, Accommodations, Expenses - Amgen; Merck Serono
 
Michele Prisciandaro
No Relationships to Disclose
 
Floriana Nappo
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca
Expert Testimony - MSD
Travel, Accommodations, Expenses - Amgen
 
Stefano Tamberi
Consulting or Advisory Role - AstraZeneca; Seagen; Takeda
Speakers' Bureau - AstraZeneca
 
Lorenzo Fornaro
Honoraria - AstraZeneca; BMS GmbH & Co. KG; Daiichi Sankyo/Astra Zeneca; MSD; SERVIER
Consulting or Advisory Role - Astellas Pharma; AstraZeneca/Daiichi Sankyo; BeiGene; MSD; SERVIER; Taiho Pharmaceutical
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); BeiGene (Inst); BMS GmbH & Co. KG (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Incyte (Inst); Janssen (Inst); Merck Sharp & Dohme (Inst); Nucana (Inst); Roche (Inst)
Travel, Accommodations, Expenses - MSD; SERVIER
 
Elisa Giommoni
No Relationships to Disclose
 
Andrea Spallanzani
Consulting or Advisory Role - Astellas Oncology; AstraZeneca; Daiichi Sankyo; Lilly; MSD
 
Samantha Di Donato
No Relationships to Disclose
 
Ferdinando De Vita
No Relationships to Disclose
 
Alessandro Bittoni
Consulting or Advisory Role - Merck Serono
Travel, Accommodations, Expenses - Roche
 
Antonia Strippoli
Consulting or Advisory Role - Bristol-Myers Squibb/Medarex (Inst)
 
Giovanni Pennoni
No Relationships to Disclose
 
Smruthy Sivakumar
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
 
Alexa Schrock
Employment - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine; Roche
 
Sabina Murgioni
No Relationships to Disclose
 
Sara Lonardi
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Beigene; Bristol-Myers Squibb; Daiichi Sankyo; Fosun Pharma; GlaxoSmithKline; Incyte; Lilly; Merck Serono; MSD; Nimbus Therapeutics; Rottapharm Biotech; SERVIER; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Incyte; Lilly; Merck Serono; MSD Oncology; Pierre Fabre; Roche; Servier
Research Funding - Amgen; AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck Serono; Roche (Inst)
 
Filippo Pietrantonio
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb; Daiichi-Sankyo; Incyte; Ipsen; Johnson&Johnson; Merck Serono; MSD Oncology; Pierre Fabre; Rottapharm Biotech; Seagen; SERVIER; Takeda
Consulting or Advisory Role - Agenus; Amgen; Astellas Pharma; AstraZeneca; Bayer; BeiGene; BMS; Daiichi-Sankyo; Gilead Sciences; GlaxoSmithKline; Incyte; Jazz Pharmaceuticals,; Johnson & Johnson/Janssen; Merck Serono; MSD Oncology; Pfizer; Pierre Fabre; Revolution Medicines; Rottapharm Biotech; SERVIER; Takeda
Research Funding - Agenus (Inst); Amgen (Inst); Astrazeneca (Inst); BeOne (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Johnson & Johnson/Janssen (Inst); Lilly (Inst); Rottapharm Biotech (Inst)
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; Johnson & Johnson/Janssen; Merck Serono; Pierre Fabre; Takeda Science Foundation
 
Giovanni Randon
Honoraria - Accademia Nazionale Di Medicina (ACCMED)
Consulting or Advisory Role - Amgen; AstraZeneca